Standardization and validation of neoLVOT assessment using three‐dimensional trans‐esophageal echocardiography before trans‐catheter mitral valve replacement
Echocardiography · 2024
DOI: 10.1111/echo.15785 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Echocardiography, 2024. Verfasst von Soha Hekal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Adult Cardiology department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt. Hauptthemen laut MEDLINE: Echocardiography, Three-Dimensional, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
Trans‐catheter mitral valve replacement (TMVR) procedures had emerged as an alternative solution for patients who are at high risk for mitral valve surgery. Although cardiac computed tomography (CT) remains the standard method for procedural planning, there is no full agreement on the best systolic phase for quantitation of the neoLVOT. Furthermore, a new three‐dimensional trans‐esophageal echocardiography (3DTEE) based software was developed to serve as filter and or an alternative for patients who cannot have CT due to any contraindication.
Aim
To determine the systolic phase of the cardiac cycle that shows the narrowest NeoLVOT area in order to standardize the way of using these software and then to validate the 3DTEE‐based software against the CT‐based one as a gold standard, in mitral valve annulus (MA) and NeoLVOT assessment.
Methods
A single center, observational, retrospective study. Initially, a sample of 20 patients (age 62 ± 4 years, 70% men) had CT‐based analysis at mid‐diastole (80%), early‐systole (10%), mid‐systole (20%), late‐systole (30%–40%), in order to detect the best systolic phase at which the neoLVOT area is the narrowest after TMVR. Then, the end systolic phase was standardized for the analysis of 49 patients (age 57 ± 6 years, 60% men), using both the commercially available CT‐based software and the newly available 3DTEE‐based software (3mensio Structural Heart, Pie Medical Imaging, The Netherlands). The 3DTEE derived parameters were compared with the gold standard CT‐based measurements.
Results
The neoLVOT area was significantly narrower at end‐systole (224 ± 62 mm 2 ), compared to early‐systole (299 ± 70 mm 2 ) and mid‐systole (261 ± 75 mm 2 ), ( p = .005). Excellent correlation was found between 3DTEE and CT measurements for MA AP diameter ( r = .96), IC diameter ( r = .92), MA area ( r = .96), MA perimeter ( r = .94) and NeoLVOT area ( r = .96), (all p ‐values < .0001). Virtual valve sizing was based on annulus measurement and was identical between CT and 3DTEE. Interobserver and intraobserver agreements were excellent for all the measurements with ICCs > .80.
Conclusions
End‐systole is the phase that shows the narrowest neoLVOT and hence should be the standard phase used during the analysis. The 3DTEE based analysis using this new software is reliable compared to the CT‐based analysis and can be serve as an alternative analysis tool in patients who cannot have CT for any clinical contraindication or as a screening test and/or filter for all patients before proceeding to a detailed CT scan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adult Cardiology department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt.
- Cardiology department, Aswan University, Aswan, Egypt.
- Cardiology department, Tanta University, Tanta, Egypt.
- Cardiology department, National Heart Institute, Cairo, Egypt.
ORCID-Profile: Hani Mahmoud-Elsayed
Zitieren
APA
Hekal, S., Emam, A. Y., Thabet, N., Shaaban, M., Bahaa, H., Elguindy, A., & Mahmoud-Elsayed, H. (2024). Standardization and validation of neoLVOT assessment using three‐dimensional trans‐esophageal echocardiography before trans‐catheter mitral valve replacement. Echocardiography. https://doi.org/10.1111/echo.15785
Vancouver
Hekal S, Emam AY, Thabet N, Shaaban M, Bahaa H, Elguindy A, et al. Standardization and validation of neoLVOT assessment using three‐dimensional trans‐esophageal echocardiography before trans‐catheter mitral valve replacement. Echocardiography. 2024. doi:10.1111/echo.15785
BibTeX
@article{Hekal2024,
author = {Hekal, Soha and Emam, Amr Y and Thabet, Nagwa and Shaaban, Mahmoud and Bahaa, Hesham and Elguindy, Ahmed and Mahmoud-Elsayed, Hani},
title = {Standardization and validation of neoLVOT assessment using three‐dimensional trans‐esophageal echocardiography before trans‐catheter mitral valve replacement},
journal = {Echocardiography},
year = {2024},
doi = {10.1111/echo.15785}
}
EUVIMED